# Eupraxia Pharmaceuticals' First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week

- URL: https://theranews.net/blog/2026-05-06-eupraxia-pharmaceuticals-first-release-of-eoehss-sub-scores-data-from-its-ongoin-0279a8/
- Published: 2026-05-06
- Type: Archive summary (AI-assisted summary of third-party reporting)
- Original outlet: benzinga
- Original report: https://www.benzinga.com/pressreleases/26/05/g52315302/eupraxia-pharmaceuticals-first-release-of-eoehss-sub-scores-data-from-its-ongoing-phase-1b2a-resol
- Topics: mental-health
- Publisher: TheraNews, operated by AdvancedCare USA Inc.
- Notice: Educational content, not medical, legal, billing or financial advice. Cite the original outlet, not this summary.

> EoEHSS (EoE Histology Scoring System) is a standardized method used to monitor esophageal tissue damage in EoE patients. Sub scores of EoEHSS are reported to specifically evaluate the tissue inflammation and tissue architecture (which is a measure of fibrosis) EoEHSS sub scores for inflammation demo

---
![Eupraxia Pharmaceuticals' First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week](/uploads/news-images/eupraxia-pharmaceuticals-first-release-of-eoehss-20260506230037.png)

---
*Originally reported by benzinga. [Read more](https://www.benzinga.com/pressreleases/26/05/g52315302/eupraxia-pharmaceuticals-first-release-of-eoehss-sub-scores-data-from-its-ongoing-phase-1b2a-resol)*

---

*Source: [https://www.benzinga.com/pressreleases/26/05/g52315302/eupraxia-pharmaceuticals-first-release-of-eoehss-sub-scores-data-from-its-ongoing-phase-1b2a-resol](https://www.benzinga.com/pressreleases/26/05/g52315302/eupraxia-pharmaceuticals-first-release-of-eoehss-sub-scores-data-from-its-ongoing-phase-1b2a-resol)*